Experimental evidence suggests that phosphodiesterase type 5 inhibitors may suppress tumor growth, postpone metastasis and prolong survival, but clinical data are lacking. A study (on the effect of phosphodiesterase type 5 inhibitors on biochemical recurrence after...
Men who show hair loss or early signs of baldness may be at an increased risk of dying from prostate cancer. A new study published in the Journal of Clinical Oncology suggests that male-pattern baldness may be linked to an increased risk for prostate cancer. The study...
The chemicals released during orgasm may protect against diseases, like prostate and breast cancer. Researchers affirmed what may be the first modifiable risk factor for prostate cancer: ejaculation. During the annual meeting of American Urological Association, a...
A new research has found that treating gum disease can offer relief to men suffering from a prostate condition that makes urination difficult. The findings showed that gum disease treatment can reduce symptoms of prostatitis, (prostate inflammation) a disease that...
Benign prostatic hyperplasia (BPH), as is medically termed, is a condition in which the prostate gland is enlarged although it isn’t cancerous. This condition occurs usually in men over the age of 60 and the percentage of men having it at the age of 70, is up to 30%....
